Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic ...
As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...
While solely API-focused players currently face increased competition, this transition is expected to strengthen long-term pricing power, improve margins, enhance compliance, and increase customer ...
Unither is an independent pharmaceutical company specialising in the development and contract manufacture of the pharmaceutical formulations that patients ...
Semaglutide has already become more than just a “vanity drug.” Clinical trials like SUSTAIN-6 and FLOW have shown it can slash the risk of kidney disease, reduce major heart attacks, and even lower ...
NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Thursday, March 5, 2026, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...
Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results